{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:37Z","timestamp":1789593097884,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jri.2026.104945","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:46:22Z","timestamp":1786171582000},"page":"104945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early prediction model for hypertensive disorders in pregnancy using cardiovascular microRNAs and maternal clinical characteristics"],"prefix":"10.1016","volume":"177","author":[{"given":"Ilona","family":"Hromadnikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kotlabova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Krofta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2026.104945_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"Low-dose aspirin use during pregnancy","volume":"132","author":"ACOG Committee Opinion No. 743","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib2","first-page":"159","article-title":"Diagnosis and management of preeclampsia and eclampsia","volume":"99","author":"ACOG practice bulletin","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2026.104945_bib4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s43032-020-00212-8","article-title":"Regulation of Uterine Spiral Artery Remodeling: a Review","volume":"27","author":"Albrecht","year":"2020","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jri.2026.104945_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104122","article-title":"Th17 \/ Treg ratio: A prospective study in a group of pregnant women with preeclampsia and fetal growth restriction","volume":"159","author":"Braga","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/uog.26233","article-title":"Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain","volume":"62","author":"Cuenca-G\u00f3mez","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","article-title":"The role of immune cells and mediators in preeclampsia","volume":"19","author":"Deer","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jri.2026.104945_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jri.2015.04.003","article-title":"Decidual natural killer cells regulate vessel stability: implications for impaired spiral artery remodelling","volume":"110","author":"Fraser","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib10","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3390\/ijms14035519","article-title":"MicroRNAs in Human Placental Development and Pregnancy Complications","volume":"14","author":"Fu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/ijms25031418","article-title":"Circulating miRNAs and Preeclampsia: From Implantation to Epigenetics","volume":"25","author":"Giannubilo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.995462","article-title":"Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia","volume":"10","author":"Hayder","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.jri.2026.104945_bib13","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.3390\/ijms23073951","article-title":"First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers","volume":"23","author":"Hromadnikova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/biomedicines10030718","article-title":"First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers","volume":"10","author":"Hromadnikova","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jri.2026.104945_bib15","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/biomedicines10102591","volume":"10","author":"Hromadnikova","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jri.2026.104945_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/biomedicines10020256","volume":"10","author":"Hromadnikova","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jri.2026.104945_bib17","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.3390\/ijms231810635","article-title":"Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications","volume":"23","author":"Hromadnikova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib18","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3390\/ijms24065177","article-title":"First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics","volume":"24","author":"Hromadnikova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2015.11.032","article-title":"Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood","volume":"137","author":"Hromadnikova","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jri.2026.104945_bib20","unstructured":"Hypertension in pregnancy: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2019 Jun 25. (NICE Guideline, No. 133.) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546004\/."},{"key":"10.1016\/j.jri.2026.104945_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/aji.12340","article-title":"Autoantibodies isolated from patients with preeclampsia induce soluble endoglin production from trophoblast cells via interactions with angiotensin II type 1 receptor","volume":"73","author":"Kobayashi","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/HYPERTENSIONAHA.110.167569","article-title":"Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes","volume":"57","author":"LaMarca","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jri.2026.104945_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1189\/jlb.0406250","article-title":"Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy","volume":"80","author":"Lash","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jri.2026.104945_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jri.2026.104945_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2020.07.011","article-title":"Pre-eclampsia predictive ability of maternal miR-125b: a clinical and experimental study","volume":"228","author":"Licini","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.jri.2026.104945_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1186\/s12884-025-08116-8","article-title":"Non-coding RNAs as diagnostic biomarkers for preeclampsia: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jri.2026.104945_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jri.2026.104945_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jri.2026.104945_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.22093","article-title":"Screening for pre-eclampsia at 11\u201313 weeks\u2019 gestation: Use of pregnancy-associated plasma protein-A, placental growth factor or both","volume":"56","author":"Mazer Zumaeta","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"121-128","key":"10.1016\/j.jri.2026.104945_bib30","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101827","article-title":"Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler","volume":"50","author":"Mendoza","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.jri.2026.104945_bib32","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jri.2026.104945_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: Comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib35","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?","volume":"10","author":"Pierik","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s43032-022-01059-x","article-title":"Preeclampsia-Derived Exosomes Imbalance the Activity of Th17 and Treg in PBMCs from Healthy Pregnant Women","volume":"30","author":"Pourakbari","year":"2023","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib37","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s43032-021-00799-6","article-title":"The Value of Circulating microRNAs for Diagnosis and Prediction of Preeclampsia: a Meta-analysis and Systematic Review","volume":"29","author":"Qin","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2026.104945_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11906-017-0784-4","article-title":"The Complement System and Preeclampsia","volume":"19","author":"Regal","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.jri.2026.104945_bib39","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1096\/fj.12-210310","article-title":"Uterine natural killer cells initiate spiral artery remodeling in human pregnancy","volume":"26","author":"Robson","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.jri.2026.104945_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jri.2026.104945_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655655","article-title":"Dysfunction of Decidual Macrophages Is a Potential Risk Factor in the Occurrence of Preeclampsia","volume":"12","author":"Rong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385950","article-title":"Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia","volume":"15","author":"Shan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: An online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.jri.2026.104945_bib46","unstructured":"Stratification of Pregnancy Management 11\u201313 Weeks\u2019 Gestation, 2023The Fetal Medicine Foundation. https:\/\/courses.fetalmedicine.com\/fmf\/show\/861?locale=en, 2025 (accessed 27 February 2025).."},{"key":"10.1016\/j.jri.2026.104945_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajog.2016.12.003","article-title":"Preventing preeclampsia with aspirin: does dose or timing matter?","volume":"216","author":"Tong","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"234","key":"10.1016\/j.jri.2026.104945_bib49","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1002\/jcp.27344","article-title":"Pre-eclampsia onset and SPARC: A possible involvement in placenta development","volume":"2019","author":"Tossetta","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jri.2026.104945_bib50","first-page":"034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.jri.2026.104945_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.951482","article-title":"The role of extravillous trophoblasts and uterine NK cells in vascular remodeling during pregnancy","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: Influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2026.104945_bib53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3389\/fimmu.2019.00792","article-title":"Macrophage Polarization in Physiological and Pathological Pregnancy","volume":"10","author":"Yao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2026.104945_bib54","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.3390\/ijms231810340","article-title":"The Impact of the Anticoagulant Type in Blood Collection Tubes on Circulating Extracellular Plasma MicroRNA Profiles Revealed by Small RNA Sequencing","volume":"23","author":"Zhelankin","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826001142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037826001142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:00:34Z","timestamp":1789592434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037826001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0165037826001142"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2026.104945","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early prediction model for hypertensive disorders in pregnancy using cardiovascular microRNAs and maternal clinical characteristics","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2026.104945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104945"}}